CareDx (CDNA) Tops Q2 EPS by 65c ; Offers Guidance

CareDx (NASDAQ: CDNA) reported Q2 EPS of $0.25, $0.65 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $92.3 million versus the consensus estimate of $67.85 million.

GUIDANCE:

CareDx sees FY2024 revenue of $320-328 million, versus the consensus of $279 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• JPMorgan Downgrades HCL Technologies (HCLT:IN) to Underweight
• St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank